Literature DB >> 11978559

Current therapeutic strategies for hyperhidrosis: a review.

Barbara Togel1, Bärbel Greve, Christian Raulin.   

Abstract

Overproduction of sweat by the exocrine sweat glands is called hyperhidrosis. It is differentiated into two forms - a localised (e.g. axillary, palmar and plantar hyperhidrosis) and a generalised form that affects the entire skin. Patients with increased sweat production often suffer from enormous psychosocial stress because they are restricted in both their private and professional lives. If the hyperhidrosis is not caused by a primary disease (e.g. hyperthyroidism or phaeochromocytoma) that can be treated, with elimination of the sweating problem, then only symptomatic treatment is possible. For axillary hyperhidrosis, local application of aluminium chloride seems to be the method of choice; an alternative is botulinum toxin whose efficacy for 3 to 9 months is an advantage. Surgical options should not be considered until conservative methods have failed. Curettage with a scraper and liposuction are reliable and safe treatments for axillary hyperhidrosis. The method of choice in treating palmoplantar hyperhidrosis is tap water iontophoresis. Adding anticholinergic substances to the water produces a more rapid therapeutic success that also lasts longer. Botulinum toxin can be an effective and promising alternative. Surgical treatment, i.e. sympathectomy, does bring about a long-term resolution of the problem, but should only be considered in well-justified cases because of the highly invasive character of the procedure. The use of systemic anticholinergic medication for patients with localised or generalised tendency to sweat can be tried, but is often limited because of the profile of adverse effects. It can be stated that in spite of the interesting and promising new alternatives, especially using botulinum toxin, the tried-and-true procedures such as tap water iontophoresis and aluminium chloride salts still have a firm place in the treatment of hyperhidrosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978559

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  7 in total

1.  Peripheral amplification of sweating--a role for calcitonin gene-related peptide.

Authors:  Tanja Schlereth; Jan Oliver Dittmar; Bianca Seewald; Frank Birklein
Journal:  J Physiol       Date:  2006-08-24       Impact factor: 5.182

2.  Comparative evaluation of botulinum toxin versus iontophoresis with topical aluminium chloride hexahydrate in treatment of palmar hyperhidrosis.

Authors:  R Rajagopal; Nikhitha B Mallya
Journal:  Med J Armed Forces India       Date:  2014-04-26

3.  The effect and persistency of 1% aluminum chloride hexahydrate iontophoresis in the treatment of primary palmar hyperhidrosis.

Authors:  Khosro Khademi Kalantari; Afsane Zeinalzade; Farzad Kobarfard; Salman Nazary Moghadam
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

Review 4.  Surgical treatment of axillary hyperhidrosis by suction-curettage of sweat glands.

Authors:  Rebeca Maffra de Rezende; Flávio Barbosa Luz
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

5.  Palmar hyperhidrosis: clinical, pathophysiological, diagnostic and therapeutic aspects.

Authors:  Flávio Ramalho Romero; Gabriela Roncada Haddad; Hélio Amante Miot; Daniele Cristina Cataneo
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

6.  Knowledge of surgical management of hyperhidrosis among primary care physicians and the general public.

Authors:  Andy Chao Hsuan Lee; Mark K Ferguson
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02

7.  A preliminary study of painless and effective transdermal botulinum toxin A delivery by jet nebulization for treatment of primary hyperhidrosis.

Authors:  Tommaso Iannitti; Beniamino Palmieri; Anna Aspiro; Alessandro Di Cerbo
Journal:  Drug Des Devel Ther       Date:  2014-07-14       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.